Imiquimod
Imiquimod is a pharmaceutical drug with 83 clinical trials. Currently 5 active trials ongoing. Historical success rate of 85.1%.
Success Metrics
Based on 57 completed trials
Phase Distribution
Phase Distribution
29
Early Stage
18
Mid Stage
26
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.8%
57 of 68 finished
16.2%
11 ended early
5
trials recruiting
83
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
Clinical Trials (83)
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod
A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia
Clinical Outcome and Biomarkers for Predicting Immunological Response in Patients Treated with Imiquimod
Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
Comparing Immune Responses to Topical Imiquimod
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions
Dendritic Cell Vaccine for Children and Adults With Sarcoma
Radiotherapy or Imiquimod in Complex Lentigo Maligna
Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
Coadministration of GA2 Sporozoites With Adjuvants
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 83